$WSBF

Waterstone Financial, Inc. (WSBF): Other Events

Waterstone Financial, Inc. (WSBF) filed an SEC Form 8-K — Other Events. Exhibit 99.1 WATERSTONE FINANCIAL, INC. WATERSTONE BANK 11200 W. PLANK CT. WAUWATOSA, WI 53226 Contact: Mark R. Gerke Chief Financial Officer 414.459.4012 markgerke@wsbonline.com FOR IMMEDIATE RELEASE WATERSTONE FINANCIAL DECLARES REGULAR QUARTERLY CASH DIVIDEND Wauwatosa, Wis. —

Original reporting
Published Sep 22, 2026, 8:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 8:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$WSBF
Bullish
medium confidence
Mentioned
$WSBF
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$WSBFBullishMed
01

Why it matters

The dividend could trigger short‑term buying by yield‑seeking traders, but long‑term impact is minimal.

02

Market read

Primary relevance is the new dividend declaration for WSBF; limited broader market effect.

03

What to watch

Potential upcoming regulatory or credit‑risk issues not disclosed in the filing.

Relevance 5/10Novelty 7/10Timing: post‑market release

Background

SEC Form 8‑K filing announcing Waterstone Financial's quarterly dividend.

Company-level read

Ticker impact

$WSBFBullishMedium confidence
Context

Board declared a regular quarterly cash dividend of $0.17 per share, payable Nov 2, 2026.

Expected impact

Modest upside potential ahead of ex-dividend date.

Evidence & confidence

Small cash dividend on a micro‑cap bank; impact limited to dividend‑capture trades.

Market effects

May slightly improve sentiment for regional banks seeking dividend yields.

Limited to Wisconsin banking market.

None

Counterpoint

Dividend may be insufficient to offset growth concerns; price could remain flat.

Key entities

  • Waterstone Financial, Inc.

    Savings and loan holding company for WaterStone Bank.

  • Mark R. Gerke

    Chief Financial Officer of Waterstone Financial.

Related articles

$WSBFMed

Waterstone Financial, Inc. (WSBF): Results of Operations and Financial Condition

Waterstone Financial, Inc. (WSBF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_967697.htm EXHIBIT 99.1 ex_967697.htm Exhibit 99.1 Waterstone Financial, Inc. Announces Results of Operations for the Quarter and Six Months Ended June 30, 2026 . WAUWATOSA, WI – 7/23/26– Waterstone Financial, Inc. (NASDAQ: WSBF), holding company for WaterStone Bank,

$RKTOHighAI 8/10

Rocket One Inc. (RKTO): Other Events

Rocket One Inc. (RKTO) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Rocket One Signs Definitive Agreement to Acquire Revenue-Generating Tracer Drone Technologies, Accelerating AI and Counter-UAS Expansion Across Public Safety and Defense Markets Transaction would add an operating drone sales, services and training platform serving pu

$INNVMedAI 8/10

Why is InnovAge stock sliding today?

InnovAge's stock fell 9.5% in after-hours trading after affiliated investment funds of Apax Partners and Welsh, Carson, Anderson & Stowe announced a secondary offering of 10 million shares. The company will not receive proceeds, signaling insider distribution. The broader market's performance did not mitigate the decline. InnovAge's Q4 revenue exceeded estimates, but earnings per share fell short. Barclays, Goldman Sachs, and Wells Fargo are managing the deal.

$IPARMed

INTERPARFUMS INC (IPAR): Other Events

INTERPARFUMS INC (IPAR) filed an SEC Form 8-K — Other Events. Exhibit 99.1 FOR IMMEDIATE RELEASE INTERPARFUMS, INC. ANNOUNCES EXCLUSIVE WORLDWIDE LICENSE AGREEMENT WITH PUMA New York, New York, September 22, 2026, Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced that it has entered into an exclusive, wo

$VTGNMedAI 8/10

Vistagen Therapeutics, Inc. (VTGN): Other Events

Vistagen Therapeutics, Inc. (VTGN) filed an SEC Form 8-K — Other Events. EXHIBIT 99.1 Vistagen Announces Preliminary Positive Data from Open-Label Extension Portion of PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Fasedienol nasal spray was well-tolerated in patients with social anxiety disorder with no new

$LONAMed

LeonaBio, Inc. (LONA): Other Events

LeonaBio, Inc. (LONA) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. In December 2025, as part of a private placement, LeonaBio, Inc. (the “Company”) issued warrants to purchase an aggregate of 23,031,494 shares of its common stock (the “Series A Common Warrants”). The Series A Common Warrants have an exercise price of $6.3